Preview

Experimental and Clinical Gastroenterology

Advanced search

Association of non-alcoholic fatty liver disease with cardiovascular disease according to autopsy data

https://doi.org/10.31146/1682-8658-ecg-203-7-38-44

Abstract

Rpose of the study. To study the relationship between fatal cardiovascular events and non-alcoholic fatty liver disease (NAFLD) among the population of the Irkutsk region. Materials and methods. The study was conducted on the basis of the Irkutsk Regional Bureau of Forensic Medicine. The object of the study was the medical documentation - “The autopsy report”. Results. To study the possible relationship, a retrospective analysis of the results of 2220 autopsies performed over 3 years was carried out: 2010-2012. in the pathological department. Signs of non-alcoholic fatty liver disease according to morphological studies were identified in 271 cases. Conclusions. 1.In patients with NAFLD, body weight can be equally normal and increased. Among patients with increased body weight, women predominate. 2. In men, there is a moderate positive correlation between the thickness of the subcutaneous fat and the mass of the liver; in women, this connection was not found. 3. Morphologically, coarse fatty degeneration of the liver is more common. 4. Every second patient with NAFLD (49%) died of CVD. Among the dead, men reliably predominate. The dominant cause of death is cardiovascular disease (AMI), followed by impaired cerebral circulation. Mortality peaks in middle and old age. 5. The total mortality from CVD for 3 years according to the pathology department of the Irkutsk Regional Clinical Hospital was 423 cases (19%) (n = 2220). Among all deaths from CVD, one in three (133 cases (31.4%)) had fatty changes in the liver. Conclusion: the results obtained confirm the hypothesis of the existence of a relationship between NAFLD and CVD, which is based on disorders of fat metabolism that develop as a result of impaired normal function of hepatocytes against the background of their fatty lesions. In accordance with this statement, it is necessary to think about considering NAFLD as a component of metabolic syndrome.

About the Authors

Olesya V. Tirikova
Irkutsk State Medical University
Russian Federation


Natalia M. Kozlova
Irkutsk State Medical University
Russian Federation


Sofia D. Kravchenko
Irkutsk State Medical University
Russian Federation


Sergey M. Eliseev
Irkutsk State Medical University
Russian Federation


Svetlana V. Lunenok
Irkutsk State Medical University
Russian Federation


Oleg V. Kanya
Irkutsk State Medical University
Russian Federation


Svetlana V. Sokolova
Irkutsk State Medical University
Russian Federation


Andrey V. Shcherbatykh
Irkutsk State Medical University
Russian Federation


Olga B. Manjaro
Irkutsk State Medical University
Russian Federation


References

1. Bueverov A.O., Maevskaya M. V. Some pathogenetic and clinical issues of nonalcoholic steatohepatitis. Clinical Prospects of Gastroenterology, Hepatology. 2003. No. 3, pp 2-7. (in Russ.) @@Буеверов А. О., Маевская М. В. Некоторые патогенетические и клинические вопросы неалкогольного стеатогепатита // Клинические перспективы гастроэнтерологии, гепатологии. - 2003. - № 3. - С. 2-7.

2. Davydova A. V. Nonalcoholic steatohepatitis: current data. Siberian Medical Journal. 2006, no. 6, pp. 96-101. (in Russ.) @@Давыдова А. В. Неалкогольный стеатогепатит: современные данные // Сибирский медицинский журнал (Иркутск). - 2006. - № 6. - С. 96-101.

3. Drapkina O.M., Gatsolaeva D. S., Ivashkin V. T. Nonalcoholic fatty liver disease in patients with metabolic syndrome. The clinician. 2007, no.6, pp. 46-50. (in Russ.) @@Драпкина О. М., Гацолаева Д. С., Ивашкин В. Т. Неалкогольная жировая болезнь печени у больных с метаболическим синдромом // Клиницист. - 2007. - № 6. - C. 46-50.

4. Chalasani N., Younossi Z., Lavine J. E., et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357. doi:10.1002/hep.29367.

5. Younossi Z. M. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70(3):531-544. doi:10.1016/j.jhep.2018.10.033.

6. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 [published correction appears in Lancet. 2019 Jun 22;393(10190): e44] [published correction appears in Lancet. 2018 Nov 17;392(10160):2170]. Lancet. 2018;392(10159):1736-1788. doi:10.1016/S0140-6736(18)32203-7.

7. Targher G., Day C. P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341-1350. doi:10.1056/NEJMra0912063.

8. Ivashkin V. T., Mayevskaya M. V., Pavlov C. S., et al. Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(2):24-42. (In Russ.) doi: 10.22416/1382-4376-2016-26-2-24-42. @@Ивашкин В. Т., Маевская М. В., Павлов Ч. С., и соавт. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(2):24-42.

9. Ong J.P., Pitts A., Younossi Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49(4):608-612. doi:10.1016/j.jhep.2008.06.018

10. Shalnova S.A., Deev A. D., Oganov R. G. Factors influencing cardiovascular mortality in Russian population. Cardiovascular Therapy and Prevention. 2005;4(1):4-9. (In Russ.)

11. Tirikova O. V., Kozlova N. M., Tarasov A. U., Eliseev S. M., Lunenok S. V. Autopsy incidence rate of fatty liver disease in the Irkutsk region. Experimental and Clinical Gastroenterology. 2020;174(4):72-76. (In Russ.) doi: 10.31146/1682-8658-ecg-176-4-72-76. @@Тирикова О. В., Козлова Н. М., Тарасов А. Ю., Елисеев С. М., Луненок C. В. Частота встречаемости жировой болезни печени в Иркутской области по результатам аутопсий. Экспериментальная и клиническая гастроэнтерология. 2020;176(4): 72-76. doi: 10.31146/1682-8658-ecg- 176-4-72-76


Review

For citations:


Tirikova O.V., Kozlova N.M., Kravchenko S.D., Eliseev S.M., Lunenok S.V., Kanya O.V., Sokolova S.V., Shcherbatykh A.V., Manjaro O.B. Association of non-alcoholic fatty liver disease with cardiovascular disease according to autopsy data. Experimental and Clinical Gastroenterology. 2022;(7):38-44. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-203-7-38-44

Views: 216


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)